0.010904
0.006295
0.000000
0.000000
0.012591
0.000000
0.000000
0.000000
0.011872
0.00000
0.00000
0.00000
Boyington, J.C.
Riaz, A.N.
Patamawenu, A.
Coligan, J.E.
Brooks, A.G.
Sun, P.D.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
12
90.00
90.00
120.00
91.710
91.710
84.230
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Immunity
IUNIEH
2048
1074-7613
10
75
82
10.1016/S1074-7613(00)80008-4
10023772
Structure of CD94 reveals a novel C-type lectin fold: implications for the NK cell-associated CD94/NKG2 receptors.
1999
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
100
1
IMAGE PLATE
1998-01
MARRESEARCH
M
x-ray
1
0.9795
1.0
X9B
NSLS
0.9795
SYNCHROTRON
NSLS BEAMLINE X9B
15004.530
CD94
C-TYPE LECTIN DOMAIN
1
man
polymer
18.015
water
39
nat
water
no
no
LQKDSDCCSCQEKWVGYRCNCYFISSEQKTWNESRHLCASQKSSLLQLQNTDELDFMSSSQQFYWIGLSYSEEHTAWLWE
NGSALSQYLFPSFETFNTKNCIAYNPNGNALDESCEDKNRYICKQQLI
LQKDSDCCSCQEKWVGYRCNCYFISSEQKTWNESRHLCASQKSSLLQLQNTDELDFMSSSQQFYWIGLSYSEEHTAWLWE
NGSALSQYLFPSFETFNTKNCIAYNPNGNALDESCEDKNRYICKQQLI
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
Escherichia
Escherichia coli
sample
NATURAL KILLER CELL
CELL SURFACE
9606
Homo sapiens
INCLUSION BODIES
511693
Escherichia coli BL21
BL21
PLASMID
MODIFIED PET30
1
3.4
63.7
7.5
pH 7.5
repository
Initial release
Version format compliance
Version format compliance
1
0
1999-06-15
1
1
2008-03-24
1
2
2011-07-13
Y
BNL
1999-01-14
REL
HOH
water
HOH
1
2
HOH
HOH
1
A
HOH
2
2
HOH
HOH
2
A
HOH
3
2
HOH
HOH
3
A
HOH
4
2
HOH
HOH
4
A
HOH
5
2
HOH
HOH
5
A
HOH
6
2
HOH
HOH
6
A
HOH
7
2
HOH
HOH
7
A
HOH
8
2
HOH
HOH
8
A
HOH
9
2
HOH
HOH
9
A
HOH
10
2
HOH
HOH
10
A
HOH
11
2
HOH
HOH
11
A
HOH
12
2
HOH
HOH
12
A
HOH
13
2
HOH
HOH
13
A
HOH
14
2
HOH
HOH
14
A
HOH
15
2
HOH
HOH
15
A
HOH
16
2
HOH
HOH
16
A
HOH
17
2
HOH
HOH
17
A
HOH
18
2
HOH
HOH
18
A
HOH
19
2
HOH
HOH
19
A
HOH
20
2
HOH
HOH
20
A
HOH
21
2
HOH
HOH
21
A
HOH
22
2
HOH
HOH
22
A
HOH
23
2
HOH
HOH
23
A
HOH
24
2
HOH
HOH
24
A
HOH
25
2
HOH
HOH
25
A
HOH
26
2
HOH
HOH
26
A
HOH
27
2
HOH
HOH
27
A
HOH
28
2
HOH
HOH
28
A
HOH
29
2
HOH
HOH
29
A
HOH
30
2
HOH
HOH
30
A
HOH
31
2
HOH
HOH
31
A
HOH
32
2
HOH
HOH
32
A
HOH
33
2
HOH
HOH
33
A
HOH
34
2
HOH
HOH
34
A
HOH
35
2
HOH
HOH
35
A
HOH
36
2
HOH
HOH
36
A
HOH
37
2
HOH
HOH
37
A
HOH
38
2
HOH
HOH
38
A
HOH
39
2
HOH
HOH
39
A
n
1
52
A
n
2
53
A
n
3
54
A
n
4
55
A
n
5
56
A
n
6
57
A
n
7
58
A
CYS
59
n
8
CYS
59
A
SER
60
n
9
SER
60
A
CYS
61
n
10
CYS
61
A
GLN
62
n
11
GLN
62
A
GLU
63
n
12
GLU
63
A
LYS
64
n
13
LYS
64
A
TRP
65
n
14
TRP
65
A
VAL
66
n
15
VAL
66
A
GLY
67
n
16
GLY
67
A
TYR
68
n
17
TYR
68
A
ARG
69
n
18
ARG
69
A
CYS
70
n
19
CYS
70
A
ASN
71
n
20
ASN
71
A
CYS
72
n
21
CYS
72
A
TYR
73
n
22
TYR
73
A
PHE
74
n
23
PHE
74
A
ILE
75
n
24
ILE
75
A
SER
76
n
25
SER
76
A
SER
77
n
26
SER
77
A
GLU
78
n
27
GLU
78
A
GLN
79
n
28
GLN
79
A
LYS
80
n
29
LYS
80
A
THR
81
n
30
THR
81
A
TRP
82
n
31
TRP
82
A
ASN
83
n
32
ASN
83
A
GLU
84
n
33
GLU
84
A
SER
85
n
34
SER
85
A
ARG
86
n
35
ARG
86
A
HIS
87
n
36
HIS
87
A
LEU
88
n
37
LEU
88
A
CYS
89
n
38
CYS
89
A
ALA
90
n
39
ALA
90
A
SER
91
n
40
SER
91
A
GLN
92
n
41
GLN
92
A
LYS
93
n
42
LYS
93
A
SER
94
n
43
SER
94
A
SER
95
n
44
SER
95
A
LEU
96
n
45
LEU
96
A
LEU
97
n
46
LEU
97
A
GLN
98
n
47
GLN
98
A
LEU
99
n
48
LEU
99
A
GLN
100
n
49
GLN
100
A
ASN
101
n
50
ASN
101
A
THR
102
n
51
THR
102
A
ASP
103
n
52
ASP
103
A
GLU
104
n
53
GLU
104
A
LEU
105
n
54
LEU
105
A
ASP
106
n
55
ASP
106
A
PHE
107
n
56
PHE
107
A
MET
108
n
57
MET
108
A
SER
109
n
58
SER
109
A
SER
110
n
59
SER
110
A
SER
111
n
60
SER
111
A
GLN
112
n
61
GLN
112
A
GLN
113
n
62
GLN
113
A
PHE
114
n
63
PHE
114
A
TYR
115
n
64
TYR
115
A
TRP
116
n
65
TRP
116
A
ILE
117
n
66
ILE
117
A
GLY
118
n
67
GLY
118
A
LEU
119
n
68
LEU
119
A
SER
120
n
69
SER
120
A
TYR
121
n
70
TYR
121
A
SER
122
n
71
SER
122
A
GLU
123
n
72
GLU
123
A
GLU
124
n
73
GLU
124
A
HIS
125
n
74
HIS
125
A
THR
126
n
75
THR
126
A
ALA
127
n
76
ALA
127
A
TRP
128
n
77
TRP
128
A
LEU
129
n
78
LEU
129
A
TRP
130
n
79
TRP
130
A
GLU
131
n
80
GLU
131
A
ASN
132
n
81
ASN
132
A
GLY
133
n
82
GLY
133
A
SER
134
n
83
SER
134
A
ALA
135
n
84
ALA
135
A
LEU
136
n
85
LEU
136
A
SER
137
n
86
SER
137
A
GLN
138
n
87
GLN
138
A
TYR
139
n
88
TYR
139
A
LEU
140
n
89
LEU
140
A
PHE
141
n
90
PHE
141
A
PRO
142
n
91
PRO
142
A
SER
143
n
92
SER
143
A
PHE
144
n
93
PHE
144
A
GLU
145
n
94
GLU
145
A
THR
146
n
95
THR
146
A
PHE
147
n
96
PHE
147
A
ASN
148
n
97
ASN
148
A
THR
149
n
98
THR
149
A
LYS
150
n
99
LYS
150
A
ASN
151
n
100
ASN
151
A
CYS
152
n
101
CYS
152
A
ILE
153
n
102
ILE
153
A
ALA
154
n
103
ALA
154
A
TYR
155
n
104
TYR
155
A
ASN
156
n
105
ASN
156
A
PRO
157
n
106
PRO
157
A
ASN
158
n
107
ASN
158
A
GLY
159
n
108
GLY
159
A
ASN
160
n
109
ASN
160
A
ALA
161
n
110
ALA
161
A
LEU
162
n
111
LEU
162
A
ASP
163
n
112
ASP
163
A
GLU
164
n
113
GLU
164
A
SER
165
n
114
SER
165
A
CYS
166
n
115
CYS
166
A
GLU
167
n
116
GLU
167
A
ASP
168
n
117
ASP
168
A
LYS
169
n
118
LYS
169
A
ASN
170
n
119
ASN
170
A
ARG
171
n
120
ARG
171
A
TYR
172
n
121
TYR
172
A
ILE
173
n
122
ILE
173
A
CYS
174
n
123
CYS
174
A
LYS
175
n
124
LYS
175
A
GLN
176
n
125
GLN
176
A
GLN
177
n
126
GLN
177
A
LEU
178
n
127
LEU
178
A
ILE
179
n
128
ILE
179
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
LEU
52
A
LEU
1
1
Y
1
A
GLN
53
A
GLN
2
1
Y
1
A
LYS
54
A
LYS
3
1
Y
1
A
ASP
55
A
ASP
4
1
Y
1
A
SER
56
A
SER
5
1
Y
1
A
ASP
57
A
ASP
6
1
Y
1
A
CYS
58
A
CYS
7
1
Y
1
A
GLU
63
-27.45
-115.12
1
A
LYS
64
-69.75
46.77
1
A
LYS
93
48.82
29.04
1
A
SER
94
-129.14
-154.41
1
A
SER
95
-173.55
143.52
1
A
LEU
96
-43.17
92.32
1
A
LEU
97
1.28
117.57
1
A
ASN
101
160.38
152.03
1
A
ASP
103
-98.93
44.55
1
A
MET
108
-58.62
3.35
1
A
SER
109
-10.23
-36.00
1
A
SER
111
-17.78
109.86
1
A
GLN
112
-84.10
38.00
1
A
THR
126
28.09
72.88
1
A
LEU
140
-64.23
-88.76
1
A
SER
143
-35.54
-33.89
1
A
PHE
144
13.03
-96.08
1
A
GLU
145
-34.35
-20.80
1
A
PHE
147
-25.40
108.34
1
A
THR
149
-31.13
-16.77
1
A
SER
165
-29.56
125.06
1
A
CYS
166
-57.66
-4.94
PROTEIN_REP.PARAM
TOPHCSDX.PRO
PARAM11.WAT
TOPH11.WAT
40.6
-18.587
-10.633
0.000
-18.587
0.000
10.638
BULK SOLVENT CORRECTION DURING REFINEMENT
0.322
0.019
0.22
0.22
2.60
8.00
279
5667
4.9
86.4
RANDOM
1000000.00
0.01
1
RESTRAINED
THROUGHOUT
2.0
MIRAS
2.60
8.00
39
1036
0
0
997
0.009
1.6
27.9
0.75
1.9
1.5
3.2
2.0
2.6
2.0
3.9
2.5
0.348
2.7
387
10
62.9
2.6
20.0
1B6E
6450
0.0
0.063
1
12.5
4.8
94.5
2.6
2.7
0.301
91.7
data reduction
DENZO
data scaling
SCALEPACK
model building
X-PLOR
3.851
refinement
X-PLOR
3.851
phasing
X-PLOR
3.851
CD94
HUMAN CD94
1
N
N
2
N
N
A
TRP
82
A
TRP
31
HELX_P
A
SER
91
A
SER
40
1
H1
10
disulf
2.036
A
CYS
59
A
SG
CYS
8
1_555
A
CYS
70
A
SG
CYS
19
1_555
disulf
2.025
A
CYS
61
A
SG
CYS
10
1_555
A
CYS
72
A
SG
CYS
21
1_555
disulf
2.027
A
CYS
89
A
SG
CYS
38
1_555
A
CYS
174
A
SG
CYS
123
1_555
disulf
2.026
A
CYS
152
A
SG
CYS
101
1_555
A
CYS
166
A
SG
CYS
115
1_555
NK CELL
NK CELL, RECEPTOR, C-TYPE LECTIN, C-TYPE LECTIN-LIKE, NKD
KLRD1_HUMAN
UNP
1
1
Q13241
MAVFKTTLWRLISGTLGIICLSLMATLGILLKNSFTKLSIEPAFTPGPNIELQKDSDCCSCQEKWVGYRCNCYFISSEQK
TWNESRHLCASQKSSLLQLQNTDELDFMSSSQQFYWIGLSYSEEHTAWLWENGSALSQYLFPSFETFNTKNCIAYNPNGN
ALDESCEDKNRYICKQQLI
52
179
1B6E
52
179
Q13241
A
1
1
128
3
4
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
VAL
66
A
VAL
15
A
TYR
68
A
TYR
17
A
ASN
71
A
ASN
20
A
ILE
75
A
ILE
24
A
ARG
171
A
ARG
120
A
GLN
176
A
GLN
125
A
ALA
127
A
ALA
76
A
LEU
129
A
LEU
78
A
TYR
115
A
TYR
64
A
SER
122
A
SER
71
A
ASN
151
A
ASN
100
A
TYR
155
A
TYR
104
A
ALA
161
A
ALA
110
A
SER
165
A
SER
114
179
P 65 2 2